author-photo

Itziar Ibarlucea-Benitez

Rockefeller University

2

Papers

15

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.

2021 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (4)
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.

2020 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (11)